Table 2.
Expression profile and location of human secretory RNases.
Human RNase | Main expression tissues and cell typesa | Presence in biological fluids: rank score or reported levelb | Subcellular locationc | Expression regulated by (in comparison with)d | ||
---|---|---|---|---|---|---|
1 |
|
|
↑ Psoriatic arthritis (vs healthy in synovial fluid) ↑ Sepsis (vs normal in whole blood and monocytes) (112) ↑ Meningococcal sepsis (at 24 h vs normal at 0 h in monocytes) ↑ Leishmaniasis (vs normal) ↑ Systemic lupus erythematosus (vs normal) ↑ Interstitial cystitis (ulcer vs normal) ↓ Francisella tularensis novicida (vs uninfect) ↓ Francisella tularensis schu S4 (vs uninfect) ↓ Mycobacterium tuberculosis (vs none in macrophages at 48 h) |
|||
2 |
|
↑ Septic shock (vs normal) ↑ Meningococcal sepsis |
||||
At 8 h, 24 h vs normal at 0 h in lymphocytes At 24 h vs normal at 0 h in blood At 0, 8, and 24 h vs normal at 0 h in monocytes At 24 h vs meningococcal sepsis at 0 h in monocytes | ||||||
|
Healthy: 163 ng/mL | |||||
|
Inflammatory bowel disease: 538 ng/mL Healthy: 18 ng/mL Inflammatory bowel disease: 95 ng/mL |
↑ Sepsis (vs normal in whole blood, CD8, and monocytes) ↑ Tuberculosis (vs normal) ↑ Leishmaniasis (vs normal) ↑ Lyme disease at acute phase of infection (vs normal) ↑ Interstitial cystitis (ulcer vs normal) ↑ Psoriasis (at lesional skin vs normal at normal skin) ↑ Burn (vs control at early stage and middle stage) ↓ Francisella tularensis novicida (vs uninfect) ↓ Mycobacterium tuberculosis (vs none in macrophage at 48 h) |
||||
3 |
|
|
↑ Meningococcal sepsis | At 24 h vs normal at 0 h in blood At 24 h vs normal at 0 h in lymphocytes At 0, 8, and 24 h vs normal at 0 h in monocytes |
||
Control: 1.7 μg/L Asthma: 2.8 μg/L Healthy: 26.1 ± 4.7 ng/mL Asthma: 142.6 ± 34.2 ng/mL |
↑ Septic shock (vs normal) (112) ↑ Lyme disease at acute phase of infection (vs normal) ↑ Leishmaniasis (vs normal) ↑ Burn (vs control at early stage and middle stage) |
|||||
|
Control: <20 μg/L Vernal keratoconjunctivitis: 470 μg/L Atopic keratoconjunctivitis:215 μg/L Giant papillary conjunctivitis: 53 μg/L |
↑ Asthma (118, 119) ↑ Inflammatory bowel disease (115) ↓ Atopic eczema (at normal skin vs normal at normal skin) |
||||
|
Healthy: 5 ng/mL Inflammatory bowel disease: 15 ng/mL |
|||||
|
Healthy: 1 ng/mL | |||||
|
Control: 3.5 ± 4.1 μg/L Reactive eosinophilia with inflammation: 75.0 ± 92.3 μg/L |
|||||
|
Control: 5.4–9.2 μg/L Helminthiases: 46–98 μg/L Atopic dermatitis: 50 μg/L Bacterial infections: 23 μg/L Malaria: 13 μg/L |
|||||
|
Interstitial cystitis:10 μg/L Normal: 32.6 ± 8.1 ng/mL Chronic non-allergic sinusitis: 87.6 ± 20.8 ng/mL Perennial allergic rhinitis: 84.7 ± 24.7 ng/mL Perennial and seasonal allergy: 112.9 ± 25.6 ng/mL |
|||||
4 |
|
|
|
↑ Sepsis (vs normal in whole blood) ↓ Visceral Leishmaniasis (vs normal) ↓ Psoriasis (at lesional skin vs normal at normal skin) |
||
5 |
|
↑ Enterococcus faecalis (vs none at 5 days) ↑ Mycobacterium tuberculosis (vs none in macrophage at 48 h) ↑ Meningococcal sepsis (at 24 h vs normal at 0 h in blood) ↑ Asthma (128) ↑ Inflammatory bowel disease (129 ↓ Francisella tularensis novicida (vs uninfect)) |
||||
|
Healthy: 394.6 ± 137.6 ng/mL |
|
↓ Francisella tularensis schu S4 (vs uninfect) | |||
|
Ulcerative colitis: 526.5 ± 224.1 ng/mL Crohn’s disease: 508.8 ± 228.5 ng/mL Crohn’s disease: 508.8 ± 228.5 ng/mL Control: 6.197 ± 1.987 ng/ml Amyotrophic lateral sclerosis: 5.582 ± 1.754 ng/mL |
↑ Psoriasis | Lesional vs non-lesional psoriasis Lesional vs normal |
|||
6 |
|
|
|
↑ Ulcerative colitis ↑ Crohn’s disease ↑ Interstitial cystitis (ulcer vs normal) ↑ Tuberculosis (vs normal) ↑ Juvenile dermatomyositis (vs normal) ↑ Interstitial fibrosis and inflammation (vs normal) ↑ Sepsis (vs normal in whole blood) ↑ Periodontitis (vs normal) |
||
|
↑ At 8 h, 24 h vs normal at 0 h in lymphocytes ↓ At 0 h vs normal at 0 h in monocytes |
|||||
↓ Francisella tularensis novicida (vs uninfect) ↓ Francisella tularensis schu S4 (vs uninfect) ↓ Mycobacterium tuberculosis (vs none in dendritic and macrophage cell at 18 and 48 h) ↓ Newcastle disease virus (at 14, 16, and 18 h vs none at 0 h) ↓ Psoriasis (vs normal) ↓ Septic shock (vs normal) ↓ Burn (middle stage vs control) | ||||||
7 |
|
Forehead: 0.93 ng/cm2 Nose: 2.7 ng/cm2 Arm: 0.94–4.9 ng/cm2 Palm: 2.0 ng/cm2 Finger: 1.5 ng/cm2 Hand back: 2.0 ng/cm2 Neck: 3.1 ng/cm2 Calf: 3.4 ng/cm2 |
↑ Sepsis (vs normal) (112) ↑ Psoriasis (lesional vs normal) ↑ Acute pyelonephritis (84) ↑ Atopic dermatitis (69) ↑ Chronic anal fistula (139) ↑ Nontypeable Haemophilus influenzae (70) ↑ Pseudomonas aeruginosa (89) ↑ Staphylococcus aureus (89) ↑ E. coli (89) ↑ Streptococcus pyogenes (89) ↑ Mycobacterium tuberculosis (140) ↓ Atopic eczema (at skin lesion and normal skin vs normal at normal skin) |
|||
8 |
|
aSummary from Uniprot (www.uniprot.org/uniprot/), Genevisible (https://genevisible.com/search), and Human Expression Atlas (https://www.ebi.ac.uk/gxa/home/).
bSummary from Bgee (https://bgee.org/) (Rank scores of expression calls are normalized across genes, conditions, and species. Low score means that the gene is highly expressed in the condition. Max rank score in all species: 4.10e4. Min rank score varies across species).
cSummary from Uniprot (www.uniprot.org/uniprot/) and Exocarta (www.exocarta.org/).
dSummary from Human Expression Atlas (https://www.ebi.ac.uk/gxa/home/). Only inflammatory, injury, and infection-related conditions are included (up and downregulation is indicated by arrows).